Manav Batra

ORCID: 0000-0003-2686-1637
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Hormonal and reproductive studies
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Diabetes and associated disorders
  • Pharmacology and Obesity Treatment
  • Adipose Tissue and Metabolism
  • Muscle metabolism and nutrition
  • Adipokines, Inflammation, and Metabolic Diseases
  • Pituitary Gland Disorders and Treatments
  • Diet and metabolism studies
  • Erythropoietin and Anemia Treatment
  • Regulation of Appetite and Obesity
  • Medical Imaging and Pathology Studies
  • Muscle Physiology and Disorders
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Hormonal Regulation and Hypertension
  • Hemoglobinopathies and Related Disorders
  • Adrenal Hormones and Disorders
  • Peptidase Inhibition and Analysis
  • Parathyroid Disorders and Treatments
  • Vitamin D Research Studies
  • Thyroid and Parathyroid Surgery
  • Bone health and treatments

University at Buffalo, State University of New York
2014-2023

Buffalo Medical Group
2018-2019

Williams (United States)
2018-2019

Kaleida Health
2013-2018

All India Institute of Medical Sciences
2013

OBJECTIVE One-third of men with type 2 diabetes have hypogonadotropic hypogonadism (HH). We conducted a randomized placebo-controlled trial to evaluate the effect testosterone replacement on insulin resistance in and HH. RESEARCH DESIGN AND METHODS A total 94 were recruited into study; 50 eugonadal, while 44 had Insulin sensitivity was calculated from glucose infusion rate (GIR) during hyperinsulinemic-euglycemic clamp. Lean body mass fat measured by DEXA MRI. Subcutaneous samples taken...

10.2337/dc15-1518 article EN Diabetes Care 2015-11-30

Abstract Context Dapagliflozin and other SGLT2 inhibitors are known to increase hematocrit, possibly due its diuretic effects hemoconcentration. Objective Since type 2 diabetes is a proinflammatory state since hepcidin, suppressor of erythropoiesis, increased in states, we investigated the possibility that dapagliflozin suppresses hepcidin concentrations thus increases erythropoiesis. Design Prospective, randomized, placebo-controlled study. Setting Single endocrinology center. Patients...

10.1210/clinem/dgaa057 article EN The Journal of Clinical Endocrinology & Metabolism 2020-02-11

To investigate whether addition of three different doses liraglutide to insulin in patients with type 1 diabetes (T1D) results significant reduction glycemia, body weight, and dose.We randomized 72 (placebo = 18, 54) T1D receive placebo 0.6, 1.2, 1.8 mg daily for 12 weeks.In the 1.2-mg 1.8-mg groups, mean weekly average blood glucose was -0.55 ± 0.11 mmol/L (10 2 mg/dL) 0.05 mg/dL), respectively (P < 0.0001), while it remained unchanged 0.6-mg groups. In group, HbA1c fell significantly...

10.2337/dc15-1136 article EN Diabetes Care 2016-04-05

It is imperative that novel approaches to treatment of type 1 diabetes (T1D) are devised.The objective the study was investigate whether addition dapagliflozin insulin and liraglutide results in a significant reduction glycemia body weight.This randomized clinical trial.The conducted at single academic medical center.Participants included T1D patients on therapy for least last 6 months.Thirty were (in 2:1 ratio) receive either 10 mg or placebo daily 12 weeks.Change mean glycated hemoglobin...

10.1210/jc.2016-1451 article EN The Journal of Clinical Endocrinology & Metabolism 2016-08-04

To investigate the effects of liraglutide treatment on glycaemic control and adipose tissue metabolism in overweight obese people with type 1 diabetes (T1DM).A total 84 adult patients T1DM, no detectable C-peptide, were randomized (1:1) to either placebo or 1.8 mg/d for 6 months. Blood samples collected at 0, 12 26 weeks. Subcutaneous biopsies, a high-calorie high-fat meal challenge test, continuous glucose monitoring, dual-energy X-ray absorptiometry MRI performed before end treatment.In...

10.1111/dom.14090 article EN Diabetes Obesity and Metabolism 2020-05-19

The purpose of this study was to determine whether an insulin infusion exerts anti-inflammatory effect and the small amounts glucose results in oxidative inflammatory stress patients with type 1 diabetes. Ten diabetes were infused either 2 U/h 100 ml 5% dextrose/h or just dextrose (100 ml/h) physiological saline for 4 h after overnight fast on three separate days. Blood samples collected at 0, 2, 4, 6 h. Insulin led maintenance euglycemia a significant suppression reactive oxygen species...

10.1152/ajpendo.00566.2012 article EN AJP Endocrinology and Metabolism 2013-02-13

As the syndrome of hypogonadotropic hypogonadism (HH) is associated with anaemia and administration testosterone restores haematocrit to normal, we investigated potential underlying mechanisms.Randomized, double-blind, placebo-controlled trial.We measured basal serum concentrations erythropoietin, iron, iron binding capacity, transferrin (saturated unsaturated), ferritin hepcidin expression ferroportin receptor (TR) in peripheral blood mononuclear cells (MNC) 94 men type 2 diabetes....

10.1111/cen.13130 article EN Clinical Endocrinology 2016-06-13

Aims One-third of males with type 2 diabetes (T2DM) have hypogonadism, characterized by low total and free testosterone concentrations. We hypothesized that this condition is associated a compensatory increase in the expression androgen receptors (AR) replacement reverses these changes. also measured estrogen receptor aromatase expression. Materials methods This randomized double-blind placebo-controlled trial. Thirty-two hypogonadal 32 eugonadal men T2DM were recruited. Hypogonadal to...

10.1530/eje-17-0673 article EN European Journal of Endocrinology 2018-01-17

Abstract Background: Fiber intake is associated with a reduction in the occurrence of cardiovascular events and diabetes. Objective: To investigate whether addition fiber to high-fat, high-calorie (HFHC) meal prevents proinflammatory changes induced by HFHC meal. Design: Ten normal fasting subjects consumed an or without additional 30 g insoluble dietary on 2 separate visits. Blood samples were collected over 5 hours, mononuclear cells (MNCs) isolated. Results: significantly lowered glucose...

10.1210/jc.2016-2669 article EN The Journal of Clinical Endocrinology & Metabolism 2016-12-01

Fibroblast growth factor (FGF)2 is an important stimulatory modulator of satellite cells in skeletal muscle. Satellite play a cardinal role muscle and repair. We evaluated whether expression FGF2 differentiation factors are reduced patients with hypogonadotropic hypogonadism (HH) testosterone replacement therapy results their restoration. This secondary analysis previously completed trial men type 2 diabetes HH. Clinical Research Center at university. Twenty-two HH 20 eugonadal were compared...

10.1210/jc.2018-01832 article EN The Journal of Clinical Endocrinology & Metabolism 2019-01-09

One-third of men with type 2 diabetes have subnormal testosterone concentrations along inappropriately normal LH and FSH concentrations. It is not known if the presence renal insufficiency affects free in diabetes.We hypothesized that diabetic chronic disease (CKD; estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m(2)) lower than function (eGFR ≥ m(2)).This a retrospective chart review patients attending nephrology clinics. Men who had following information available were...

10.1530/eje-15-0359 article EN European Journal of Endocrinology 2015-06-23

Abstract Context Adenosine 5’-monophosphate-activated protein kinase-α (AMPKα) is a mediator of exercise-induced glucose uptake in skeletal muscle. Objective We evaluated whether AMPKα expression and phosphorylation are reduced muscle adipose tissue patients with hypogonadotropic hypogonadism (HH), testosterone replacement therapy results restoration the AMPKα. Design This secondary analysis previously completed trial that showed an insulin-sensitizing effect men type 2 diabetes HH. Setting...

10.1210/clinem/dgz288 article EN The Journal of Clinical Endocrinology & Metabolism 2019-12-20

To investigate the mechanisms underlying improvements in blood pressure (BP) and congestive heart failure outcomes following treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor.A total of 52 patients type 2 diabetes (T2D) an HbA1c less than 8% participated this prospective, double-blind placebo-controlled study. Patients were randomized (1:1) to either dapagliflozin 10 mg daily or placebo for 12 weeks. Half also monitored 6 h their first dose acute effects on BP. Blood...

10.1111/dom.14377 article EN Diabetes Obesity and Metabolism 2021-03-17

In view of the occurrence diabetic ketoacidosis associated with use sodium‐glucose transport protein‐2 inhibitors in patients type 1 diabetes ( T1DM ) and relative absence this complication treated liraglutide spite reductions insulin doses, we investigated effect on ketogenesis. Twenty‐six inadequately controlled were randomly divided into 2 groups 13 each. After an overnight fast, injected, subcutaneously, either 1.8 mg or placebo. They maintained their basal infusion followed up our...

10.1111/dom.12944 article EN Diabetes Obesity and Metabolism 2017-03-17

In view of the known vasodilatory effects glucagon‐like peptide‐1 and exenatide, we investigated exenatide on vasoactive factors. We analysed blood samples mononuclear cells ( MNCs ) from a previous study, collected after single dose 12 weeks or placebo treatment in series 24 patients with type 2 diabetes mellitus. After treatment, plasma concentrations atrial natriuretic peptide, cyclic guanyl monophosphate cGMP adenyl increased significantly at weeks. Plasma adenylate cyclase expression...

10.1111/dom.12835 article EN Diabetes Obesity and Metabolism 2016-11-28

This study was conducted to investigate whether a high-fat/high-carbohydrate (HFHC) meal induces an increase in plasma concentrations of glucagon, dipeptidyl peptidase-IV (DPP-IV), and CD26 expression mononuclear cells (MNC) while reducing insulin, C-peptide, proinsulin, GIP, GLP-1 concentrations. Ten healthy normal subjects were given either 910-calorie HFHC or American Heart Association (AHA) rich fruit fiber during the first visit other second crossover design. Blood samples collected at...

10.1152/ajpendo.00275.2014 article EN AJP Endocrinology and Metabolism 2014-11-19

Summary We conducted a randomised trial comparing lidocaine 2% gel with proparacaine 0.5% eye drops in children having elective squint surgery. One hundred and forty aged between 3 14 years were recruited. The requirement for intra‐operative fentanyl postoperative ibuprofen was significantly less the group compared (1 (1.7%) vs 12 (18.5%), p = 0.002 16 (27.6%) 38 (58.5%), 0.001, respectively). incidence of nausea vomiting (6 (10.3%) (24.6%), 0.04). There no differences groups terms severity...

10.1111/anae.12286 article EN Anaesthesia 2013-06-13

Background and Hypothesis . Following our recent demonstration that the chronic inflammatory insulin resistant state of obesity is associated with an increase in expression mediators known to contribute pathogenesis asthma weight loss after gastric bypass surgery results reduction these genes, we have now hypothesized suppresses cellular plasma concentrations mediators. Methods The IL-4, LIGHT, LTBR, ADAM-33, TSLP MNC TGF- β 1, MMP-9, MCP-1, TSLP, NOM obese patients T2DM were measured...

10.1155/2015/202406 article EN cc-by Journal of Diabetes Research 2015-01-01

We previously demonstrated the anti-inflammatory and antioxidant effects of exenatide. now hypothesized that exenatide also increases plasma concentration interleukin-1 receptor antagonist (IL-1RA), an endogenous protein, modulates nuclear factor erythroid 2‒related factor‒Kelchlike ECH-associated protein 1‒antioxidant response element (Nrf-2‒Keap-1‒ARE) system to induce key enzymes suppress inflammatory oxidative stress. Twenty-four patients with obesity type 2 diabetes receiving combined...

10.1210/jc.2017-02343 article EN The Journal of Clinical Endocrinology & Metabolism 2018-01-15

One-third of men with type 2 diabetes have subnormal free testosterone concentrations. We evaluated the following: (i) whether bone mineral density (BMD) and strength are affected by gonadal status in (ii) effect replacement on markers osteoblast osteoclast activity.This is a secondary analysis previously completed, randomized, placebo-controlled trial. Ninety-four were recruited; 44 had Men concentrations randomized to receive intramuscular injections or placebo every weeks for 22 weeks....

10.1210/js.2018-00426 article EN cc-by-nc-nd Journal of the Endocrine Society 2019-07-01

We report the case of a 54-year-old Caucasian female who presented with two-year history persistent hypocalcemia requiring multiple hospitalizations. Her medical was significant for HIV diagnosed four years ago. She denied any prior neck surgery or radiation. vital signs were stable an unremarkable physical exam. Pertinent medications included calcium carbonate, vitamin D3, calcitriol, efavirenz, emtricitabine, tenofovir disoproxil, hydrochlorothiazide, and inhaled budesonide/formoterol....

10.1155/2018/8270936 article EN cc-by Case Reports in Endocrinology 2018-09-25
Coming Soon ...